Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virological Response Switching to Atripla (ONCE)
NCT00615745Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Apr 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Apr 2008; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00615745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615745.